Desensitization with plasma exchange in a patient with human leukocyte antigen donor‐specific antibodies before T‐cell–replete haploidentical transplantation

Abstract

This case report suggests that the adopted scheme is safe for reducing DSA levels and facilitating donor engraftment in patients scheduled for haplo-HSCT.